Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation
- 31 January 2005
- journal article
- case report
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 24 (1), 102-104
- https://doi.org/10.1016/j.healun.2003.10.014
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for managementThe Journal of Heart and Lung Transplantation, 2003
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisThe New England Journal of Medicine, 2002
- Small bowel infarction secondary to aspergillosis in a post-cardiac transplant patient: a case report.The Journal of Heart and Lung Transplantation, 2002
- The Clinical Spectrum of Pulmonary AspergillosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2002
- Mortality and Costs of Acute Renal Failure Associated with Amphotericin B TherapyClinical Infectious Diseases, 2001
- Practice Guidelines for Diseases Caused by AspergillusClinical Infectious Diseases, 2000
- Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven AspergillosisClinical Infectious Diseases, 1999
- Invasive AspergillosisClinical Infectious Diseases, 1998